Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive
Ping-Tao Tseng1, Yu Lee, Pao-Yen Lin
1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, [corrected] Kaohsiung, Taiwan.
Background:
Many studies have supported the role of neurotrophic hypothesis in the pathophysiology of mood disorders. This study examined serum levels of glial cell line-derived neurotrophic factor (GDNF), one of the neurotrophic factors, in patients with major depressive disorder (MDD) at different disease states.
Methods:
The serum GDNF levels were measured in 55 patients with MDD (29 severe patients and 26 remitted patients) and 35 healthy controls by ELISA method. Severity of depressive symptoms was assessed using the 17-item Hamilton Rating Scale of Depression (HAM-D) (HAM-D >/= 19 for severe MDD, HAM-D = 7 for remitted MDD).
Results:
MDD patients were found to have significantly lower serum GDNF levels than healthy controls (p<0.001). This decrease was significant in older-aged (p=0.003) and middle-aged (p=0.026) groups, but not in the younger-aged group. We found no difference in GDNF level between severe and remitted MDD patients.
Conclusions:
In spite of some limitations, our results indicate an age-associated reduction in serum GDNF levels in patients with MDD, further supporting the role of the neurotrophic factor as a disease marker and a new target for developing antidepressant treatment.
Related Concept Videos
Decreasing Function
Glial Cells
Pharmacodynamics in Geriatric Patients: Effects of Age
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...

